Free Trial

Dynavax Technologies Q4 2024 Earnings Report

Dynavax Technologies logo
$12.65 -0.20 (-1.56%)
As of 04:00 PM Eastern

Dynavax Technologies EPS Results

Actual EPS
$0.05
Consensus EPS
$0.05
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Dynavax Technologies Revenue Results

Actual Revenue
$72.03 million
Expected Revenue
$72.70 million
Beat/Miss
Missed by -$673.00 thousand
YoY Revenue Growth
N/A

Dynavax Technologies Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Remove Ads

Dynavax Technologies Earnings Headlines

Dynavax Files Preliminary Proxy Statement
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Deep Track Capital sends letter to Dynavax Technologies’ board
Dynavax to execute debt refinancing
See More Dynavax Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Dynavax Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dynavax Technologies and other key companies, straight to your email.

About Dynavax Technologies

Dynavax Technologies (NASDAQ:DVAX), a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

View Dynavax Technologies Profile

More Earnings Resources from MarketBeat